Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1994 May;144(5):986–996.

Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.

K Yoshioka 1, S Hino 1, T Takemura 1, S Maki 1, J Wieslander 1, Y Takekoshi 1, H Makino 1, M Kagawa 1, Y Sado 1, C E Kashtan 1
PMCID: PMC1887361  PMID: 8178947

Abstract

Although the evidence indicates that mutation of the gene for the alpha 5 chain of type IV collagen, alpha 5-(IV), is the primary defect in X-linked Alport syndrome, protein data for the alpha 5(IV) chain with regard to its normal distribution and its distribution in patients with Alport syndrome is lacking. We produced a rat monoclonal antibody (H51) by immunizing rats with a synthetic peptide corresponding to the nonconsensus amino acid sequence of alpha 5(IV) NC1 domain. H51 reacted by Western blotting with 26-kd cationic monomers and associated dimers of human type IV collagen NC1 domain. Immunohistochemical studies demonstrated that in normal human kidney alpha 5(IV) was present in the glomerular basement membrane and basement membranes of the Bowman's capsule and in some tubules (collecting ducts). The alpha 5(IV) chain was also detected in the basement membranes of normal skin, eye, and lung. Male patients with X-linked Alport syndrome revealed no reactivity of renal and epidermal basement membranes with H51, whereas alpha 5(IV) staining was normal in the glomerular basement membrane of patients with other types of glomerular diseases, including benign familial hematuria. The staining was also normal in the skin of nonaffected males in X-linked Alport families. Female heterozygous for Alport syndrome exhibited a discontinuous or mosaic pattern in the immunofluorescent staining of the epidermal basement membrane. These findings confirm that in patients with X-linked Alport syndrome there are abnormalities in alpha 5(IV) in renal and epidermal basement membranes at the protein level. Immunofluorescent staining of skin biopsies with this antibody may be of value in making a diagnosis of Alport syndrome, and, furthermore, may aid in detecting carrier females in whom urinary abnormalities are often mild or silent.

Full text

PDF
986

Images in this article

989Figure 1
on p.989
990Figure 2
on p.990
991Figure 3
on p.991
992Figure 4
on p.992
993Figure 5
on p.993
994Figure 6
on p.994

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arahata K., Hoffman E. P., Kunkel L. M., Ishiura S., Tsukahara T., Ishihara T., Sunohara N., Nonaka I., Ozawa E., Sugita H. Dystrophin diagnosis: comparison of dystrophin abnormalities by immunofluorescence and immunoblot analyses. Proc Natl Acad Sci U S A. 1989 Sep;86(18):7154–7158. doi: 10.1073/pnas.86.18.7154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barker D. F., Hostikka S. L., Zhou J., Chow L. T., Oliphant A. R., Gerken S. C., Gregory M. C., Skolnick M. H., Atkin C. L., Tryggvason K. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science. 1990 Jun 8;248(4960):1224–1227. doi: 10.1126/science.2349482. [DOI] [PubMed] [Google Scholar]
  3. Butkowski R. J., Shen G. Q., Wieslander J., Michael A. F., Fish A. J. Characterization of type IV collagen NC1 monomers and Goodpasture antigen in human renal basement membranes. J Lab Clin Med. 1990 Mar;115(3):365–373. [PubMed] [Google Scholar]
  4. Butkowski R. J., Wieslander J., Kleppel M., Michael A. F., Fish A. J. Basement membrane collagen in the kidney: regional localization of novel chains related to collagen IV. Kidney Int. 1989 May;35(5):1195–1202. doi: 10.1038/ki.1989.110. [DOI] [PubMed] [Google Scholar]
  5. Butkowski R. J., Wieslander J., Wisdom B. J., Barr J. F., Noelken M. E., Hudson B. G. Properties of the globular domain of type IV collagen and its relationship to the Goodpasture antigen. J Biol Chem. 1985 Mar 25;260(6):3739–3747. [PubMed] [Google Scholar]
  6. Geysen H. M., Rodda S. J., Mason T. J., Tribbick G., Schoofs P. G. Strategies for epitope analysis using peptide synthesis. J Immunol Methods. 1987 Sep 24;102(2):259–274. doi: 10.1016/0022-1759(87)90085-8. [DOI] [PubMed] [Google Scholar]
  7. Griffin C. A., Emanuel B. S., Hansen J. R., Cavenee W. K., Myers J. C. Human collagen genes encoding basement membrane alpha 1 (IV) and alpha 2 (IV) chains map to the distal long arm of chromosome 13. Proc Natl Acad Sci U S A. 1987 Jan;84(2):512–516. doi: 10.1073/pnas.84.2.512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gunwar S., Saus J., Noelken M. E., Hudson B. G. Glomerular basement membrane. Identification of a fourth chain, alpha 4, of type IV collagen. J Biol Chem. 1990 Apr 5;265(10):5466–5469. [PubMed] [Google Scholar]
  9. Hostikka S. L., Eddy R. L., Byers M. G., Höyhtyä M., Shows T. B., Tryggvason K. Identification of a distinct type IV collagen alpha chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome. Proc Natl Acad Sci U S A. 1990 Feb;87(4):1606–1610. doi: 10.1073/pnas.87.4.1606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hoyer J. R., Sisson S. P., Vernier R. L. Tamm-Horsfall glycoprotein: ultrastructural immunoperoxidase localization in rat kidney. Lab Invest. 1979 Aug;41(2):168–173. [PubMed] [Google Scholar]
  11. Ishikawa E., Imagawa M., Hashida S., Yoshitake S., Hamaguchi Y., Ueno T. Enzyme-labeling of antibodies and their fragments for enzyme immunoassay and immunohistochemical staining. J Immunoassay. 1983;4(3):209–327. doi: 10.1080/15321818308057011. [DOI] [PubMed] [Google Scholar]
  12. Johansson C., Butkowski R., Wieslander J. Characterization of monoclonal antibodies to the globular domain of collagen IV. Connect Tissue Res. 1991;25(3-4):229–241. doi: 10.3109/03008209109029159. [DOI] [PubMed] [Google Scholar]
  13. Kashtan C. E., Kleppel M. M., Butkowski R. J., Michael A. F., Fish A. J. Alport syndrome, basement membranes and collagen. Pediatr Nephrol. 1990 Sep;4(5):523–532. doi: 10.1007/BF00869840. [DOI] [PubMed] [Google Scholar]
  14. Kashtan C., Fish A. J., Kleppel M., Yoshioka K., Michael A. F. Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis. J Clin Invest. 1986 Oct;78(4):1035–1044. doi: 10.1172/JCI112658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kleppel M. M., Michael A. F. Expression of novel basement membrane components in the developing human kidney and eye. Am J Anat. 1990 Feb;187(2):165–174. doi: 10.1002/aja.1001870205. [DOI] [PubMed] [Google Scholar]
  16. Kleppel M. M., Michael A. F., Fish A. J. Antibody specificity of human glomerular basement membrane type IV collagen NC1 subunits. Species variation in subunit composition. J Biol Chem. 1986 Dec 15;261(35):16547–16552. [PubMed] [Google Scholar]
  17. Kleppel M. M., Santi P. A., Cameron J. D., Wieslander J., Michael A. F. Human tissue distribution of novel basement membrane collagen. Am J Pathol. 1989 Apr;134(4):813–825. [PMC free article] [PubMed] [Google Scholar]
  18. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  19. Lyon M. F. X-chromosome inactivation and developmental patterns in mammals. Biol Rev Camb Philos Soc. 1972 Jan;47(1):1–35. doi: 10.1111/j.1469-185x.1972.tb00969.x. [DOI] [PubMed] [Google Scholar]
  20. Mariyama M., Kalluri R., Hudson B. G., Reeders S. T. The alpha 4(IV) chain of basement membrane collagen. Isolation of cDNAs encoding bovine alpha 4(IV) and comparison with other type IV collagens. J Biol Chem. 1992 Jan 15;267(2):1253–1258. [PubMed] [Google Scholar]
  21. Morrison K. E., Mariyama M., Yang-Feng T. L., Reeders S. T. Sequence and localization of a partial cDNA encoding the human alpha 3 chain of type IV collagen. Am J Hum Genet. 1991 Sep;49(3):545–554. [PMC free article] [PubMed] [Google Scholar]
  22. Murata F., Tsuyama S., Suzuki S., Hamada H., Ozawa M., Muramatsu T. Distribution of glycoconjugates in the kidney studied by use of labeled lectins. J Histochem Cytochem. 1983 Jan;31(1A):139–144. [PubMed] [Google Scholar]
  23. Pihlajaniemi T., Tryggvason K., Myers J. C., Kurkinen M., Lebo R., Cheung M. C., Prockop D. J., Boyd C. D. cDNA clones coding for the pro-alpha1(IV) chain of human type IV procollagen reveal an unusual homology of amino acid sequences in two halves of the carboxyl-terminal domain. J Biol Chem. 1985 Jun 25;260(12):7681–7687. [PubMed] [Google Scholar]
  24. Reeders S. T. Molecular genetics of hereditary nephritis. Kidney Int. 1992 Sep;42(3):783–792. doi: 10.1038/ki.1992.348. [DOI] [PubMed] [Google Scholar]
  25. Sado Y., Kagawa M., Rauf S., Naito I., Moritoh C., Okigaki T. Isologous monoclonal antibodies can induce anti-GBM glomerulonephritis in rats. J Pathol. 1992 Oct;168(2):221–227. doi: 10.1002/path.1711680211. [DOI] [PubMed] [Google Scholar]
  26. Tryggvason K., Zhou J., Hostikka S. L., Shows T. B. Molecular genetics of Alport syndrome. Kidney Int. 1993 Jan;43(1):38–44. doi: 10.1038/ki.1993.8. [DOI] [PubMed] [Google Scholar]
  27. Yoshioka K., Kleppel M., Fish A. J. Analysis of nephritogenic antigens in human glomerular basement membrane by two-dimensional gel electrophoresis. J Immunol. 1985 Jun;134(6):3831–3837. [PubMed] [Google Scholar]
  28. Yoshioka K., Michael A. F., Velosa J., Fish A. J. Detection of hidden nephritogenic antigen determinants in human renal and nonrenal basement membranes. Am J Pathol. 1985 Oct;121(1):156–165. [PMC free article] [PubMed] [Google Scholar]
  29. Yoshioka K., Morimoto Y., Iseki T., Maki S. Characterization of tubular basement membrane antigens in human kidney. J Immunol. 1986 Mar 1;136(5):1654–1660. [PubMed] [Google Scholar]
  30. Yoshioka K., Takemura T., Murakami K., Akano N., Matsubara K., Aya N., Maki S. Identification and localization of epidermal growth factor and its receptor in the human glomerulus. Lab Invest. 1990 Aug;63(2):189–196. [PubMed] [Google Scholar]
  31. Zhou J., Barker D. F., Hostikka S. L., Gregory M. C., Atkin C. L., Tryggvason K. Single base mutation in alpha 5(IV) collagen chain gene converting a conserved cysteine to serine in Alport syndrome. Genomics. 1991 Jan;9(1):10–18. doi: 10.1016/0888-7543(91)90215-z. [DOI] [PubMed] [Google Scholar]
  32. Zhou J., Hertz J. M., Tryggvason K. Mutation in the alpha 5(IV) collagen chain in juvenile-onset Alport syndrome without hearing loss or ocular lesions: detection by denaturing gradient gel electrophoresis of a PCR product. Am J Hum Genet. 1992 Jun;50(6):1291–1300. [PMC free article] [PubMed] [Google Scholar]
  33. Zhou J., Mochizuki T., Smeets H., Antignac C., Laurila P., de Paepe A., Tryggvason K., Reeders S. T. Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors. Science. 1993 Aug 27;261(5125):1167–1169. doi: 10.1126/science.8356449. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES